The Impact of Significance Level and Hypothesis Testing in Biomedical Data Analysis

The research analyzes the impact of significance levels and hypothesis testing in biomedical data analysis. By conducting a systematic review of 19 peer-reviewed studies, we examined the relationship between selected significance levels (α=0.01, 0.05, 0.10) and the occurrence of Type I and Type II errors. The findings reveal that the majority of studies employed a significance level of α=0.05, resulting in Type I error rates ranging from 0.040 to 0.050. In contrast, studies utilizing a more stringent significance level of α=0.01 reported lower Type I errors but exhibited higher Type II errors, indicating a tendency to overlook true treatment effects. Furthermore, only 50% of studies that achieved statistical significance adequately addressed the clinical relevance of their findings. These results underscore the necessity for researchers to carefully consider their choice of significance level and to explicitly communicate the clinical implications of their results. This analysis highlights the critical role of rigorous hypothesis testing in enhancing the reliability and applicability of biomedical research outcomes, ultimately contributing to improved patient care and treatment strategies. Future research should focus on establishing standardized reporting practices that bridge the gap between statistical significance and clinical relevance.